S. Zinner

John J. Wright, R. Olsen, S. Garattini, 1987, Progress in Drug Research/Fortschritte der Arzneimittelforschung/Progrès des recherches pharmaceutiques.

Fosfomycin trometamol versus pipemidic acid in the treatment of bacteriuria in pregnancy.

S. Zinner, 1990, Chemotherapy.

Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic patients

H. Gaya, J. Klastersky, S. Schimpff, 1986, Antimicrobial Agents and Chemotherapy.

Bacteriuria and renal disease.

E. Kass, S. Zinner, 1969, The Journal of infectious diseases.

Management of urinary tract infections in pregnancy: A review with comments on single dise therapy

S. Zinner, 1992 .

Vaginal colonization with Corynebacterium vaginale (Haemophilus vaginalis).

B. Rosner, W. Mccormack, S. Zinner, 1977, The Journal of infectious diseases.

Clinical Overview of Enoxacin

S. Zinner, 1989, Clinical pharmacokinetics.

Brief Review of Fungal Infections

W. Scheld, S. Zinner, 1990, Pharmacotherapy.

Inability of counterimmunoelectrophoresis to detect echovirus in cerebrospinal fluid.

P. Shank, G. Peter, S. Zinner, 1983, American journal of clinical pathology.

Countercurrent immunoelectrophoresis in the diagnosis of viral infections of the central nervous system.

F. D. Meglio, S. Zinner, F. Garrity, 1978, The Journal of infectious diseases.

The search for new antimicrobials: why we need new options

S. Zinner, 2005, Expert review of anti-infective therapy.

Paul Ehrlich, a prescient pioneer in the field of antimicrobial chemotherapy: what did he foresee a century ago?

G. Tillotson, S. Zinner, 2013, Expert review of anti-infective therapy.

Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses.

S. Zinner, A. Firsov, S. Vostrov, 2000, International journal of antimicrobial agents.

Comparative Pharmacodynamics of Gatifloxacin and Ciprofloxacin in an In Vitro Dynamic Model: Prediction of Equiefficient Doses and the Breakpoints of the Area under the Curve/MIC Ratio

S. Zinner, A. Firsov, I. Lubenko, 2000, Antimicrobial Agents and Chemotherapy.

The effects of sodium, chloride, and calcium concentration on the response of melanophores to melanocyte-stimulating hormone (MSH).

S. Zinner, R. R. Novales, B. J. Novales, 1962, General and comparative endocrinology.

Enrichment of Fluoroquinolone-Resistant Staphylococcus aureus: Oscillating Ciprofloxacin Concentrations Simulated at the Upper and Lower Portions of the Mutant Selection Window

S. Zinner, A. Firsov, M. V. Smirnova, 2008, Antimicrobial Agents and Chemotherapy.

Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.

S. Zinner, A. Firsov, M. V. Smirnova, 2008, International journal of antimicrobial agents.

Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model.

S. Zinner, A. Firsov, Y. Portnoy, 2013, The Journal of antimicrobial chemotherapy.

Comparative Pharmacodynamics and Antimutant Potentials of Doripenem and Imipenem with Ciprofloxacin-Resistant Pseudomonas aeruginosa in an In Vitro Model

S. Zinner, A. Firsov, Y. Portnoy, 2011, Antimicrobial Agents and Chemotherapy.

The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models.

S. Zinner, A. Firsov, S. A. Dovzhenko, 2009, The Journal of antimicrobial chemotherapy.

Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.

S. Zinner, A. Firsov, M. V. Smirnova, 2009, International journal of antimicrobial agents.

ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.

A. P. Arzamastsev, S. Zinner, A. Firsov, 2004, The Journal of antimicrobial chemotherapy.

Concentration-dependent changes in the susceptibility and killing of Staphylococcus aureus in an in vitro dynamic model that simulates normal and impaired gatifloxacin elimination.

S. Zinner, A. Firsov, Y. Portnoy, 2004, International journal of antimicrobial agents.

Prevention of the selection of resistant Staphylococcus aureus by moxifloxacin plus doxycycline in an in vitro dynamic model: an additive effect of the combination.

S. Zinner, A. Firsov, Y. Portnoy, 2004, International journal of antimicrobial agents.

Comparative pharmacodynamics of moxifloxacin and levofloxacin in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and equiefficient doses.

S. Zinner, A. Firsov, Y. Portnoy, 2000, The Journal of antimicrobial chemotherapy.

MPC-Based Prediction of Anti-Mutant Effectiveness of Antibiotic Combinations: In Vitro Model Study with Daptomycin and Gentamicin against Staphylococcus aureus

S. Zinner, A. Firsov, M. Golikova, 2021, Antibiotics.

Concentration-response relationships as a basis for choice of the optimal endpoints of the antimicrobial effect: daptomycin and vancomycin pharmacodynamics with staphylococci in an in vitro dynamic model.

S. Zinner, A. Firsov, M. V. Smirnova, 2007, International journal of antimicrobial agents.

Sexually transmitted conditions among women college students.

B. Rosner, C. Laughlin, W. Mccormack, 1981, American journal of obstetrics and gynecology.

Resistance studies with Streptococcus pneumoniae using an in vitro dynamic model: amoxicillin versus azithromycin at clinical exposures

S. Zinner, A. Firsov, S. A. Dovzhenko, 2019, Journal of chemotherapy.

Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships.

S. Zinner, A. Firsov, Y. Portnoy, 2001, Diagnostic microbiology and infectious disease.

New pathogens in the immunocompromised host.

S. Zinner, 1993, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Limited protective effect of rough mutant antisera in murine Escherichia coli bacteremia

S. Zinner, J. Ryff, M. Keating, 1982, Infection.

Erythromycin and alkalinisation of urine in the treatment of urinary-tract infections due to gram-negative bacilli.

M. Finland, L. Sabath, S. Zinner, 1971, Lancet.

A comparative study of methods for the detection of antibodies to core glycolipids.

S. Zinner, G. Peter, 1979, European Journal of Cancer.

The potential role of cell wall core glycolipids in the immunoprophylaxis and immunotherapy of gram-negative rod bacteraemia

S. Zinner, G. Peter, 1983 .

Opsonization of serum-sensitive and serum-resistant Escherichia coli by rough mutant (Re) antisera.

S. Zinner, James Crowley, G. Peter, 1982, Journal of Laboratory and Clinical Medicine.

Fifteen-month follow-up study of women infected with Chlamydia trachomatis.

W M McCormack, S H Zinner, S Alpert, 1979, The New England journal of medicine.

The epidemiology of bacteriuria in pregnancy

S. Zinner, 1990, International Urogynecology Journal.

Erythromycin plus alkalinization in treatment of urinary infections.

M. Finland, S. Zinner, J. Casey, 1969, Antimicrobial agents and chemotherapy.

Treatment of gram-negative bacteremia in patients with cancer and granulocytopenia.

E. Anaissie, T. Calandra, M. Glauser, 1988, The New England journal of medicine.

Two compartment kinetic model with multiple artificial capillary units.

J. Blaser, J Blaser, B B Stone, 1985, The Journal of antimicrobial chemotherapy.

Bacteriuria and babies revisited.

S. Zinner, 1979, The New England journal of medicine.

Serum Bactericidal Activity of Moxalactam and Cefotaxime With and Without Tobramycin Against Pseudomonas aeruginosa and Staphylococcus aureus

J. Klastersky, H. Lagast, S. Zinner, 1981, Antimicrobial Agents and Chemotherapy.

In-vitro studies of antibiotic combinations with special emphasis on the evaluation of newly developed methods.

J. Blaser, S. Zinner, 1986, The Journal of antimicrobial chemotherapy.

Rapid method for determining serum bactericidal activity.

S. Zinner, R. B. Provonchee, 1974, Applied microbiology.

Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection

A. Medeiros, M. Dudley, P. Pivarnik, 1994, Antimicrobial Agents and Chemotherapy.

Predicting effects of antibiotic combinations using MICs determined at pharmacokinetically derived concentration ratios: in vitro model studies with linezolid- and rifampicin-exposed Staphylococcus aureus

S. Zinner, A. Firsov, S. A. Dovzhenko, 2017, Journal of chemotherapy.

Klebsiella pneumoniae Susceptibility to Carbapenem/Relebactam Combinations: Influence of Inoculum Density and Carbapenem-to-Inhibitor Concentration Ratio

A. V. Filimonova, O. Sulian, V. Ageevets, 2022, Biomedicines.

Predicting the antistaphylococcal effects of daptomycin–rifampicin combinations in an in vitro dynamic model

S. Zinner, A. Firsov, M. Golikova, 2019, The Journal of Antibiotics.

Predicting antibiotic combination effects on the selection of resistant Staphylococcus aureus: In vitro model studies with linezolid and gentamicin.

S. Zinner, A. Firsov, M. Golikova, 2018, International journal of antimicrobial agents.

Simulated in vitro Quinolone Pharmacodynamics at Clinically Achievable AUC/MIC Ratios: Advantage of IE over Other Integral Parameters

S. Zinner, A. Firsov, Y. Portnoy, 2003, Chemotherapy.

The pharmacodynamics of gatifloxacin and ciprofloxacin for pneumococci in an in vitro dynamic model: prediction of equiefficient doses.

S. Zinner, A. Firsov, D. Gilbert, 2001, The Journal of antimicrobial chemotherapy.

Use of modeling techniques to aid in antibiotic selection

S. Zinner, A. Firsov, 2001, Current infectious disease reports.

Predicting bacterial resistance using the time inside the mutant selection window: possibilities and limitations.

S. Zinner, A. Firsov, E. Strukova, 2014, International journal of antimicrobial agents.

Microencapsulation of erythrom ycin and clarithrom ycin using a spray-drying technique

G. Goffinet, S. Zinner, S. Zgoulli, 1999 .

Microencapsulation of erythromycin and clarithromycin using a spray-drying technique.

P. Thonart, G. Goffinet, S. Zinner, 1999, Journal of microencapsulation.

Prediction of the Effects of Inoculum Size on the Antimicrobial Action of Trovafloxacin and Ciprofloxacin againstStaphylococcus aureus and Escherichia coli in an In Vitro Dynamic Model

S. Zinner, A. Firsov, Y. Portnoy, 1999, Antimicrobial Agents and Chemotherapy.

Chlamydia trachomatis in women: antibody in cervical secretions as a possible indicator of genital infection.

B. Rosner, W. Mccormack, S. Zinner, 1979, The Journal of infectious diseases.

Relevant aspects in the Infectious Diseases Society of America (IDSA) guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever.

S. Zinner, 1998, International journal of hematology.

Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin.

S. Zinner, A. Firsov, M. Golikova, 2021, The Journal of antimicrobial chemotherapy.

Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model

M. Edelstein, S. Zinner, A. Firsov, 2017, The Journal of antimicrobial chemotherapy.

Familial aggregation of urinary kallikrein concentration in childhood: relation to blood pressure, race and urinary electrolytes.

B. Rosner, H. Margolius, H. Keiser, 1976, American journal of epidemiology.

Eikenella Corrodens and Other Similar Bacteria: A Review of Laboratory Aspects and Clinical Significance

W. Mccormack, S. Zinner, G. Brooks, 1974 .

Vaginal Colonization with Mycoplasma hominis and Ureaplasma urealyticum

B. Rosner, W. Mccormack, S. Zinner, 1986, Sexually Transmitted Diseases.

Bacteriology of the human gallbladder in cholelithiasis and cholecystitis.

D. Fry, S. Zinner, L. F. Martin, 1983, The American surgeon.

Infection with Chlamydia trachomatis in female college students.

B. Rosner, W. Mccormack, S. Zinner, 1985, American journal of epidemiology.

Antibiotic Development and the Evolving Role of Pharmacodynamics — As Good as It Gets?

G. Tillotson, S. Zinner, 2015, EBioMedicine.

Comparative pharmacodynamics of the new fluoroquinolone ABT492 and levofloxacin with Streptococcus pneumoniae in an in vitro dynamic model.

S. Zinner, A. Firsov, M. V. Smirnova, 2005, International journal of antimicrobial agents.

Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.

S. Zinner, A. Firsov, Y. Portnoy, 2004, International journal of antimicrobial agents.

Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model.

R. Vasilov, S. Zinner, A. Firsov, 1999, The Journal of antimicrobial chemotherapy.

Bacterial strain-independent AUC/MIC and strain-specific dose-response relationships reflecting comparative fluoroquinolone anti-pseudomonal pharmacodynamics in an in vitro dynamic model.

S. Zinner, A. Firsov, Y. Portnoy, 2002, International journal of antimicrobial agents.

Evaluation of self-obtained cultures using a vaginal tampon as a method of screening for asymptomatic gonorrhea on a college campus.

W. Mccormack, S. Zinner, S. Alpert, 1974, Journal of the American Venereal Disease Association.

The Incidence of Genitourinary Infections in a Cohort of Healthy Women

S. Zinner, WILLIAM M. McCORMACK, W. MICHAEL MCCORMACK, 1994, Sexually transmitted diseases.

Comparison of methods for the isolation of genital mycoplasmas from men.

P. Tarr, W. Mccormack, S. Zinner, 1976, The Journal of infectious diseases.

Isolation of Eikenella corrodens in a General Hospital

A. Daly, W. Mccormack, S. Zinner, 1973, Applied microbiology.

Neonatal Blood Pressure and Salt Taste Responsiveness

B. Rosner, L. Lipsitt, S. McGarvey, 2002, Hypertension.

Factors affecting blood pressures in newborn infants.

B. Rosner, W. Oh, E. Kass, 1980, HYPERTENSION.

BLOOD PRESSURE IN INFANCY

S. McGarvey, S. Zinner, 1956, Seminars in Nephrology.

Predicting the Effects of Carbapenem/Carbapenemase Inhibitor Combinations against KPC-Producing Klebsiella pneumoniae in Time-Kill Experiments: Alternative versus Traditional Approaches to MIC Determination

A. V. Filimonova, S. Zinner, M. Golikova, 2021, Antibiotics.

Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils.

S. Zinner, I. B. Kadenatsi, L. V. Shustova, 2002, The Journal of antimicrobial chemotherapy.

Use of an in-vitro kinetic model to study antibiotic combinations.

J. Blaser, S. Zinner, B. B. Stone, 1985, The Journal of antimicrobial chemotherapy.

Effect of dose on serum pharmacokinetics of intravenous ciprofloxacin with identification and characterization of extravascular compartments using noncompartmental and compartmental pharmacokinetic models

M. Dudley, S. Zinner, J. Ericson, 1987, Antimicrobial Agents and Chemotherapy.

Meropenem MICs at Standard and High Inocula and Mutant Prevention Concentration Inter-Relations: Comparative Study with Non-Carbapenemase-Producing and OXA-48-, KPC- and NDM-Producing Klebsiella pneumoniae

O. Sulian, V. Ageevets, S. Zinner, 2023, Antibiotics.

Fluorescence Microscopy: Determination of Meropenem Activity against Klebsiella pneumoniae

S. Zinner, M. Golikova, K. Alieva, 2023, Antibiotics.

Antimicrobial therapy in cancer patients: Studies from the EORTC international antimicrobial therapy cooperative group

S. Zinner, 1997 .

Testing the mutant selection window hypothesis with meropenem: In vitro model study with OXA-48-producing Klebsiella pneumoniae

S. Sidorenko, O. Sulian, V. Ageevets, 2023, PloS one.

Comparative pharmacodynamics of telithromycin and clarithromycin with Streptococcus pneumoniae and Staphylococcus aureus in an in vitro dynamic model: focus on clinically achievable antibiotic concentrations.

S. Zinner, A. Firsov, Y. Portnoy, 2005, International journal of antimicrobial agents.

Comparative Activities of Ciprofloxacin and Levofloxacin againstStreptococcus pneumoniae in an In Vitro Dynamic Model

S. Zinner, D. Gilbert, K. Simmons, 2000, Antimicrobial Agents and Chemotherapy.

Early granulocyte transfusions in high risk febrile neutropenic patients.

H. Gaya, J. Klastersky, S. Zinner, 1983, Schweizerische medizinische Wochenschrift. Supplementum.

Sexual behavior and contraceptive use. Changes from 1975 to 1995 in college women.

J. Peipert, W. Mccormack, S. Zinner, 1997, Journal of reproductive medicine.

College women and condom use, 1975-1995.

J. Peipert, W. Mccormack, S. Zinner, 1996, New England Journal of Medicine.

Bacterial antibiotic resistance studies using in vitro dynamic models: Population analysis vs. susceptibility testing as endpoints of mutant enrichment.

S. Zinner, A. Firsov, E. Strukova, 2015, International journal of antimicrobial agents.

Species differences in ciprofloxacin resistance among Gram-negative bacteria: can “anti-mutant” ratios of the area under the concentration–time curve to the MIC be achieved clinically?

S. Zinner, A. Firsov, E. Strukova, 2017, Journal of chemotherapy.

Management of urinary tract infections in pregnancy: A review with comments on single dise therapy

S. Zinner, D. S.H.ZinnerM., 2005, Infection.